HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4-(3-3,4-p-menthadien-(1,8)-yl)olivetol

has vasodilating activity
Also Known As:
abn-cbd; abnormal cannabidiol
Networked: 17 relevant articles (5 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Abdel-Rahman, Abdel A: 3 articles (02/2018 - 10/2014)
2. Bermúdez-Silva, Francisco J: 2 articles (01/2022 - 01/2020)
3. Cobo-Vuilleumier, Nadia: 2 articles (01/2022 - 01/2020)
4. Escamilla-Sánchez, Alejandro: 2 articles (01/2022 - 01/2020)
5. Gauthier, Benoit R: 2 articles (01/2022 - 01/2020)
6. González-Mariscal, Isabel: 2 articles (01/2022 - 01/2020)
7. Pozo-Morales, Macarena: 2 articles (01/2022 - 01/2020)
8. Romero-Zerbo, Silvana Y: 2 articles (01/2022 - 01/2020)
9. Sánchez-Salido, Lourdes: 2 articles (01/2022 - 01/2020)
10. El-Moselhy, Mohamed A: 2 articles (02/2018 - 01/2017)

Related Diseases

1. Insulin Resistance
2. Hypotension (Low Blood Pressure)
3. Inflammation (Inflammations)
4. Type 1 Diabetes Mellitus (Autoimmune Diabetes)
5. Colitis

Related Drugs and Biologics

1. 4-(3-3,4-p-menthadien-(1,8)-yl)olivetol
2. Insulin (Novolin)
3. Glucose (Dextrose)
4. Sitagliptin Phosphate (Januvia)
5. O-1602 compound
6. Paclitaxel (Taxol)
7. Cannabinoids
8. Cannabidiol
9. anandamide (arachidonylethanolamide)
10. CB2 Cannabinoid Receptor

Related Therapies and Procedures

1. Glycemic Control